We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image
  • Published In : Nov 2023
  • Code : CMI5922
  • Pages :150
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Global cerebral angiography market is expected to be valued at US$ 14.96 Bn in 2023. It is projected to exhibit a CAGR of 6.1% from 2023 to 2030, to reach US$ 22.64 Bn. The market growth is primarily driven by increasing prevalence of neurological disorders, advancements in imaging technology, and growing demand for minimally invasive diagnostic procedures.

  • Cerebral angiography plays a vital role in diagnosing and assessing conditions such as stroke, aneurysms, and arteriovenous malformations by utilizing contrast agents and X-ray imaging to capture detailed images of blood vessels in the brain. Technological advancements, including high-resolution detectors and advanced image processing software, have enhanced the quality and accuracy of cerebral angiography images, further driving market growth.
  • Moreover, the market is expanding beyond diagnostics into interventional procedures such as endovascular treatments. This expansion is driven by the ability of cerebral angiography to guide and facilitate precise interventions within the blood vessels of the brain.
  • Global cerebral angiography market face challenges like the procedure requires skilled operators due to its invasiveness, and the availability of alternative imaging modalities may impact its adoption. There are potential risks associated with the use of contrast agents that need to be considered.
  • Global cerebral angiography market is witnessing significant growth due to increasing prevalence of neurological disorders, advancements in imaging technology, and the demand for minimally invasive diagnostic and interventional procedures. Overcoming challenges and leveraging further technological advancements will be crucial for sustaining market growth in the coming years.

Global Cerebral Angiography Market- Regional Insights

  • North America cerebral angiography market held the dominant position due to advanced healthcare infrastructure, well-established reimbursement policies, and high adoption of advanced medical technologies. The U.S., in particular, has been a major contributor to the North America market growth due to its robust healthcare system and ongoing technological advancements. It is projected that North America will continue to dominate the market, capturing a share of 45% in 2023. The region  growth is fueled by factors such as the high prevalence of stroke, increasing investments in the development of cerebral angiography technologies, and the presence of a large number of key players.
  • Europe is another prominent region in the cerebral angiography market, with countries like Germany, the U.K., France, and Italy witnessing substantial growth. The region benefits from a well-developed healthcare sector, an increasing geriatric population, and a rising prevalence of cerebrovascular diseases. Europe is expected to be the second-largest market, holding a share of 30% in 2023. The market growth in Europe is driven by factors such as rising demand for minimally invasive procedures, increasing government initiatives, and presence of a large number of key players.
  • Asia Pacific has emerged as a lucrative market for cerebral angiography, fueled by improving healthcare infrastructure, rising disposable income, and increasing awareness about advanced medical imaging techniques. Countries like China, Japan, and India are experiencing significant market growth due to their large patient pool, increasing healthcare expenditure, and government initiatives aimed at enhancing healthcare facilities. Asia Pacific is expected to be the fastest-growing market, with a projected compound annual growth rate (CAGR) of 6.1% during the forecast period. The region growth is attributed to factors such as the rising prevalence of stroke, increasing investments in the development of cerebral angiography technologies, and growing awareness about the benefits of cerebral angiography.

Analyst Viewpoint

  • Global cerebral angiography market is poised to grow steadily over the next few years. Advances in imaging technologies allows for higher resolution images and less invasive procedures, and this boosts adoption of cerebral angiography. Rising geriatric population globally who are more prone to neurovascular disorders can propel the market growth. Furthermore, increasing awareness about benefits of early diagnosis and treatment of neurological conditions is encouraging more patients to opt for angiography tests. However, the market also faces some challenges. High cost of angiography devices and procedures may limit growth in price sensitive regions. Potential risks and complications associated with invasive angiography such as groin puncture may discourage some patients and physicians. The market will continue benefiting from ongoing research into developing more user-friendly and safer angiography systems

Figure 1. Global Cerebral Angiography Market Share (%), By Region, 2023


To learn more about this report, request a free sample copy

Global Cerebral Angiography Market- Drivers

  • Increasing prevalence of cerebrovascular diseases: Rising incidence of cerebrovascular diseases such as strokes, aneurysms, and arteriovenous malformations (AVMs) is a significant driver for the cerebral angiography market growth. As these conditions require accurate diagnosis and treatment, cerebral angiography plays a crucial role in visualizing and evaluating blood vessels in the brain. For instance, according to World Health Organization, every year, 15 million people worldwide suffer a stroke. Of these, 5 million die and another 5 million remain permanently disabled, placing a strain on families and communities. Strokes rarely occur in people under 40 year of age.  In this case, high blood pressure is the main cause.
  • Advancements in imaging technology: Technological advancements in cerebral angiography techniques have improved the accuracy, safety, and efficiency of the procedure. The development of digital subtraction angiography (DSA), 3D rotational angiography, and flat-panel detector technology has enhanced image quality and reduced radiation exposure for patients, and thus, boosting demand for cerebral angiography.
  • Growing geriatric population: Aging population is prone to various neurological disorders and vascular conditions that leads to increased demand for cerebral angiography. With the older population predicted to grow in the next years, the market is expected to benefit from the increased prevalence of cerebrovascular illnesses in this demographic.
  • Increasing awareness and healthcare infrastructure: Growing awareness among patients and healthcare professionals about the benefits of early detection and intervention for cerebrovascular diseases has increased demand for cerebral angiography. The expansion of healthcare infrastructure, especially in emerging economies, has improved access to advanced medical technologies, including cerebral angiography systems.

Global Cerebral Angiography Market- Opportunities

  • Technological advancements: Continuous advancements in imaging technology, such as improvements in image resolution, faster acquisition times, and the development of hybrid imaging systems, offer significant opportunities for the cerebral angiography market. Emerging technologies like artificial intelligence (AI) and machine learning (ML) can assist in automated image analysis and interpretation, enhancing the efficiency and accuracy of cerebral angiography procedures.
  • Expansion in emerging markets: There is growing demand for advanced medical imaging technologies, including cerebral angiography, in emerging markets. Rapidly developing healthcare infrastructure, increasing healthcare expenditure, and a rising middle-class population with higher disposable income contribute to the market's potential in countries such as China, India, Brazil, and others. Manufacturers and service providers can capitalize on these opportunities by expanding their presence and establishing partnerships in these regions.
  • Integration with other medical specialties: Cerebral angiography can benefit from integration with other medical specialties, such as neurosurgery, interventional radiology, and cardiology. Collaborative approaches and interdisciplinary practices can lead to improved patient outcomes and better utilization of cerebral angiography techniques. Opportunities exist for cross-specialty training, knowledge sharing, and collaborative research to enhance the application and effectiveness of cerebral angiography.
  • Rising demand for outpatient and ambulatory care: The shift towards outpatient and ambulatory care settings presents opportunities for the cerebral angiography market. Minimally invasive procedures, shorter recovery times, and advancements in imaging technology allow for performing cerebral angiography in outpatient settings. This trend offers convenience to patients, reduces healthcare costs, and opens avenues for the market to expand into outpatient clinics and ambulatory surgical centers.

Cerebral Angiography Market Report Coverage

Report Coverage Details
Base Year: 2023 Market Size in 2023: US$ 14.96 Bn
Historical Data for: 2018 to 2022 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 6.1% 2030 Value Projection: US$ 22.64 Bn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel and Rest of Middle East
  • Africa: North Africa, Central Africa and South Africa
Segments covered:
  • By Imaging Technique: Digital Subtraction Angiography (DSA), Magnetic Resonance Angiography (MRA), Computed Tomography Angiography (CTA), Catheter Angiography, Intraoperative Angiography, and Other Advanced Imaging Techniques
  • By Indication: Intracranial Aneurysms, Arteriovenous Malformations (AVMs), Stroke, Cerebral Tumors, Cerebrovascular Disease, and Others
  • By End User: Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Academic and Research Institutions
  • By Product Type: Angiography Systems, Catheters, Guidewires, Contrast Media, and Accessories and Consumables
  • By Patient Age: Adult Patients and  Pediatric Patients
Companies covered:

Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems Corporation, Shimadzu Corporation, Medtronic plc, Stryker Corporation, Terumo Corporation, Boston Scientific Corporation, AngioDynamics, Inc., Penumbra, Inc., MicroPort Scientific Corporation, Cook Medical LLC and Cordis

Growth Drivers:
  • Increasing prevalence of cerebrovascular diseases
  • Advancements in imaging technology
  • Growing geriatric population
  • Increasing awareness and healthcare infrastructure
Restraints & Challenges:
  • High cost of procedures
  • Potential risks and complications
  • Availability of alternative imaging modalities

Global Cerebral Angiography Market- Trends

  • Shift towards minimally invasive procedures: There is growing preference for minimally invasive procedures in healthcare. This trend is also evident in the field of cerebral angiography, where patients and healthcare providers are increasingly opting for less invasive approaches. Minimally invasive techniques reduce patient discomfort, shorten recovery times, and minimize the risk of complications associated with traditional surgical procedures. As a result, there is rising demand for catheter-based angiography procedures and non-invasive imaging modalities such as CT angiography and MR angiography.
  • Integration of advanced imaging technologies: The integration of advanced imaging technologies is revolutionizing cerebral angiography. Innovations such as 3D rotational angiography, flat-panel detector systems, and cone-beam CT have significantly improved image quality, visualization, and diagnostic accuracy. These technologies allow detailed and precise assessment of cerebral vasculature, and thus, aiding in the diagnosis and treatment planning for cerebrovascular conditions.
  • Growing application of artificial intelligence (AI): Artificial intelligence is increasingly being applied in medical imaging, including cerebral angiography. AI algorithms can assist in image interpretation, automated analysis, and quantitative measurements, improving the efficiency and accuracy of cerebral angiography procedures. AI has the potential to aid in the detection of abnormalities, identification of high-risk patients, and treatment planning, thereby enhancing patient outcomes.
  • Increasing adoption of hybrid imaging systems: Hybrid imaging systems that combine multiple modalities, such as angiography with CT or MRI, are gaining traction in cerebral angiography. These hybrid systems provide complementary information, allowing for comprehensive evaluation of both anatomical and functional aspects of the cerebrovascular system. The integration of angiography with other imaging modalities offers a more comprehensive understanding of the underlying pathologies and facilitates better treatment decision-making.

Global Cerebral Angiography Market- Restraints

  • High cost of procedures: Cerebral angiography procedures can be expensive, involving costs associated with imaging equipment, contrast agents, catheters, and specialized healthcare personnel. The high cost of procedures can limit accessibility, particularly in regions with limited healthcare budgets or inadequate insurance coverage. Affordability concerns can hinder the market growth and restrict patient access to cerebral angiography services.
  • Potential risks and complications: Like any medical procedure, cerebral angiography carries certain risks and potential complications. These may include allergic reactions to contrast agents, catheter-related complications, radiation exposure, and the risk of stroke or other adverse events. Concerns about these risks can influence patient and physician decision-making and may impact the adoption of cerebral angiography.
  • Availability of alternative imaging modalities: Cerebral angiography competes with alternative imaging modalities such as CT angiography (CTA) and MR angiography (MRA) that offer non-invasive imaging of the cerebral vasculature. While cerebral angiography provides high-resolution images and remains the gold standard for certain indications, non-invasive modalities have seen advancements in image quality and accessibility. The availability of alternative imaging options may limit the growth potential of cerebral angiography in certain cases.

Global Cerebral Angiography Market- Recent Developments

New product launches

  • GE Healthcare: In January 2022, GE Healthcare, medical technology company launched Revolution 360 Cerebral Angiography System. The new system provides high-quality 3D rotational angiography with 50% dose reduction as compared to previous systems. This helped GE Healthcare to strengthen its portfolio of neurovascular solutions and gain market share in the growing cerebral angiography market.
  • Siemens Healthineers : In December 2020, Siemens Healthineers, provider of healthcare solution and services introduced the Artis icono Family of angiography systems that includes the Artis icono biplane and Artis icono floor systems. These systems offer advanced imaging capabilities and flexible configurations for a range of interventional procedures, including cerebral angiography.

Acquisition and partnerships

  • Canon Medical Systems Corporation and Varian Medical Systems: In June 2021, Canon, Japanese Multinational Corporation, acquired Varian Medical Systems for US$ 16.4 billion. This major acquisition expanded Canon's capabilities in cancer care solutions including cerebral angiography systems. It established Canon as a leading player in the medical devices industry with access to Varian's large global customer base.

Key Developments

  • Philips Healthcare, health technology company continues its investment in spectral CT with the launch of the Spectral CT 7500, a new flagship CT scanner designed to make performing spectral imaging even easier for everyday routine use.

Figure 2. Global Cerebral Angiography Market Share (%), By Indication, 2023


To learn more about this report, request a free sample copy

Top companies in Global Cerebral Angiography Market

  • Siemens Healthineers AG
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Shimadzu Corporation
  • Medtronic plc
  • Stryker Corporation
  • Terumo Corporation
  • Boston Scientific Corporation
  • AngioDynamics, Inc.
  • Penumbra, Inc.
  • MicroPort Scientific Corporation
  • Cook Medical LLC
  • Cordis

*Definition: Cerebral angiography is a medical imaging procedure that involves the visualization of blood vessels in the brain using contrast agents and X-ray technology. It is performed to diagnose and evaluate various cerebrovascular conditions such as aneurysms, arteriovenous malformations (AVMs), and blockages in the blood vessels. During the procedure, a catheter is threaded through the blood vessels to inject a contrast dye, which helps to highlight the blood vessels on X-ray images. Cerebral angiography provides detailed information about the structure and function of the blood vessels in the brain, aiding in diagnosis and treatment planning for cerebrovascular disorders.

Frequently Asked Questions

The key factors hampering the growth of the global cerebral angiography market are the high cost of procedures, potential risks and complications, availability of alternative imaging modalities, limited awareness and education, need for specialized expertise, and regulatory and reimbursement challenges.

The major factors driving the growth of the market are the increasing prevalence of cerebrovascular diseases, advancements in imaging technology, growing geriatric population, demand for minimally invasive procedures, technological investments and research, supportive reimbursement policies, and expanding healthcare infrastructure.

The leading indication  segment in the market is the Cerebral Tumors segment, due to advanced diagnostic technologies such as cerebral angiography plays a vital role in identifying the location, size and boundaries of brain tumors, which aids surgeons in meticulous planning of tumor removal surgeries. Cerebral angiography allows for precise visualization of blood vessels and their relationship with tumors. This helps minimize damage to critical brain areas during surgeries.

Some of the major players operating in the market include Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems Corporation, Shimadzu Corporation, Medtronic plc, Stryker Corporation, Terumo Corporation, Boston Scientific Corporation, AngioDynamics, Inc., Penumbra, Inc., MicroPort Scientific Corporation, Cook Medical LLC and Cordis

North America is expected to lead the market.

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount

Reliability and Reputation

DUNS Registered
DMCA Protected


Reliability and Reputation


Reliability and Reputation


Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo